Clauss Fibrinogen Assay – Study Guide &
Clinical Interpretation
Aim
To understand the principles behind the Clauss assay for measuring plasma fibrinogen
concentration and its clinical significance in diagnosing and monitoring coagulation
disorders.
Introduction to Fibrinogen Measurement
Measurement of plasma fibrinogen plays an important role in clinical diagnostics. It is
widely used for the diagnosis and monitoring of bleeding disorders and thrombotic
conditions. In addition, fibrinogen levels can serve as a risk marker for cardiovascular
disease.
Fibrinogen is the final substrate in the coagulation cascade, where it is converted into
fibrin during clot formation. It is also classified as a positive acute-phase reactant,
meaning that its concentration increases during inflammation or tissue injury.
Elevated fibrinogen levels have been associated with conditions such as:
• Myocardial infarction
• Stroke
• Inflammatory diseases
Because of this, fibrinogen can act as a biomarker for cardiovascular risk.
Clinically, fibrinogen measurement is also important for distinguishing between
disorders such as:
• Hypofibrinogenemia – reduced fibrinogen levels
• Dysfibrinogenemia – abnormal fibrinogen function
The Clauss Assay
The Clauss assay is considered the gold standard method for determining plasma
fibrinogen concentration in clinical laboratories.
Its popularity in diagnostics is due to:
• High specificity for fibrinogen
• Good reproducibility
Clinical Interpretation
Aim
To understand the principles behind the Clauss assay for measuring plasma fibrinogen
concentration and its clinical significance in diagnosing and monitoring coagulation
disorders.
Introduction to Fibrinogen Measurement
Measurement of plasma fibrinogen plays an important role in clinical diagnostics. It is
widely used for the diagnosis and monitoring of bleeding disorders and thrombotic
conditions. In addition, fibrinogen levels can serve as a risk marker for cardiovascular
disease.
Fibrinogen is the final substrate in the coagulation cascade, where it is converted into
fibrin during clot formation. It is also classified as a positive acute-phase reactant,
meaning that its concentration increases during inflammation or tissue injury.
Elevated fibrinogen levels have been associated with conditions such as:
• Myocardial infarction
• Stroke
• Inflammatory diseases
Because of this, fibrinogen can act as a biomarker for cardiovascular risk.
Clinically, fibrinogen measurement is also important for distinguishing between
disorders such as:
• Hypofibrinogenemia – reduced fibrinogen levels
• Dysfibrinogenemia – abnormal fibrinogen function
The Clauss Assay
The Clauss assay is considered the gold standard method for determining plasma
fibrinogen concentration in clinical laboratories.
Its popularity in diagnostics is due to:
• High specificity for fibrinogen
• Good reproducibility
